Scientists had finally identified the 21 drugs that may be effective in treating COVID-10--four of them might be used with remdesivir. According to The Daily Mail's latest report, 21 compounds identified by scientists showed promising results in treating the viral disease. The drugs include those leprosy medicines that were already approved, and failed experimental cancer treatments and allergy drugs.
A global team of scientists just revealed 21 drugs that could stop the replication of SARS-CoV-2, the virus that causes Covid-19.
Four of these drugs work in synergy with remdesivir, a treatment that was emergency-approved for Covid-19 treatment pic.twitter.com/X2XAm61kLa — Mwesigye Abraham (@AbrahamMwesigye) July 29, 2020
The report confirmed that the U.S. FDA already approves clofazimine since 1986. "Tetrandrine" (Hangfangchin A) will be the second drug, an older form of the controversial malaria drug hydroxychloroquine. The U.S. FDA does not yet approve it since it is currently in phase 3 trials.
The third drug will be "Apilimod," which is currently under development to treat cancer and autoimmune diseases. It can treat COVID-19 by preventing the virus from entering cells. "Ono 5334" is the fourth drug that could be partnered with Remdesivir. It is an experimental osteoporosis medicine to prevent human bone from being reabsorbed. This drug is said to have the ability to prevent SARS-CoV-2 from entering the cells by blocking the activity of an enzyme. Keep your tabs open for updates of the COVID-19 drug at TechTimes.
Visit our website at https://www.techtimes.com/
This article is owned by TechTimes,
Written by: Giuliano de Leon.
